A leading global life sciences corporation was exploring strategic alternatives including a possible company sale. A private equity firm interested in acquiring the company engaged Ocean Tomo to perform due diligence on the potential target company’s patent portfolio. To support the bid price calculation, the client required an understanding of the content and quality of the company’s intellectual property assets and their impact on the company’s business.
Ocean Tomo provided a series of qualitative and quantitative analyses of the target company’s patent portfolio and market environment.
Ocean Tomo quantified the top intellectual-property related risks to revenue build and market share due to patent expirations. We identified patents expiring in key patent families and the vulnerabilities created by those expirations. Further, we identified numerous high quality recently issued or pending patents that could offset the key expirations. The client made the determination not to pursue the acquisition.